Aptose Biosciences (TSX:APS) 3-Year Dividend Growth Rate : 0.00% (As of Dec. 2024)

View and export this data going back to 1993. Start your Free Trial

What is Aptose Biosciences 3-Year Dividend Growth Rate?

Aptose Biosciences's Dividends per Share for the three months ended in Dec. 2024 was C$0.00.

The historical rank and industry rank for Aptose Biosciences's 3-Year Dividend Growth Rate or its related term are showing as below:

TSX:APS's 3-Year Dividend Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 10.2
* Ranked among companies with meaningful 3-Year Dividend Growth Rate only.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Aptose Biosciences's Dividend Payout Ratio for the three months ended in Dec. 2024 was 0.00. As of today, Aptose Biosciences's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Aptose Biosciences's 3-Year Dividend Growth Rate

For the Biotechnology subindustry, Aptose Biosciences's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aptose Biosciences's 3-Year Dividend Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aptose Biosciences's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Aptose Biosciences's 3-Year Dividend Growth Rate falls into.

Save Embed

;

Save Embed

;

Aptose Biosciences 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Aptose Biosciences (TSX:APS) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Aptose Biosciences's Dividend Payout Ratio for the quarter that ended in Dec. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Dec. 2024 )	/	EPS without NRI (Q: Dec. 2024 )
	=	0	/	-1.607
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aptose Biosciences 3-Year Dividend Growth Rate Related Terms>

Aptose Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptose Biosciences Inc (TSX:APS) » Definitions » 3-Year Dividend Growth Rate

Comparable Companies

Traded in Other Exchanges

APTOF:USA 0UI8:UK LTI0:Germany

Address

66 Wellington Street West, Suite 5300, TD Bank Tower Box 48, Toronto, ON, CAN, M5K 1E6

Website

https://www.aptose.com

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.

Executives

Bernd Robert Seizinger	Director
William Glenn Rice	Director, Senior Officer
Erich Platzer	Director
Rafael Bejar	Senior Officer
Warren Whitehead	Director
Gregory Kwok Lee Chow	Senior Officer
Jotin Marango	Senior Officer

Aptose Biosciences Headlines

No Headlines